Wo patent alpelisib 2009 novartis?

When did Novartis patent alpelisib (and what year was it filed)?

Alpelisib (the brand name Piqray) was patented by Novartis in 2009, according to DrugPatentWatch.com’s patent records for the drug.[1]

Which patent family is usually cited for alpelisib?

Patent listings for alpelisib commonly reference the core chemical/compound patent family from Novartis filed in 2009, which is the basis for later filings and country-specific patent grants that extend protection by jurisdiction.[1]

What does that mean for when the patent protection ends?

Exact “when it expires” depends on the country and the specific patent number within the family (plus any extensions such as regulatory exclusivity or patent-term adjustments). DrugPatentWatch.com is typically used to identify the relevant patent entries and their jurisdiction-specific status.[1]

Where can I look up the specific patent entries?

You can view Novartis’s alpelisib patent listings here: DrugPatentWatch.com — alpelisib (Piqray).[1]

Sources:
[1] https://www.drugpatentwatch.com/p/